| Ethelind Cacho Cahigas, PT | |
|
529 N Porter St Apt B, Seaford, DE 19973-2449 | |
| (408) 394-9649 | |
| Not Available |
| Full Name | Ethelind Cacho Cahigas |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 24 Years |
| Location | 529 N Porter St Apt B, Seaford, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336388644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | J10002314 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bass Medical Group | 9032111281 | 309 |
News Archive
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.
Amedisys Inc., one of the nation's largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Meanwhile McClatchy is reporting that, based on an analysis of Medicare's list of banned providers, Miami is at the top for Medicare fraud.
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.
XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis.
› Verified 4 days ago
| Provider Name | Tri-valley Orthopedic And Sports Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184808156 PECOS PAC ID: 3577461151 Enrollment ID: O20031219000786 |
News Archive
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.
Amedisys Inc., one of the nation's largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Meanwhile McClatchy is reporting that, based on an analysis of Medicare's list of banned providers, Miami is at the top for Medicare fraud.
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.
XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis.
› Verified 4 days ago
| Provider Name | Bass Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174253405 PECOS PAC ID: 9032111281 Enrollment ID: O20070201000181 |
News Archive
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.
Amedisys Inc., one of the nation's largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Meanwhile McClatchy is reporting that, based on an analysis of Medicare's list of banned providers, Miami is at the top for Medicare fraud.
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.
XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ethelind Cacho Cahigas, PT 529 N Porter St Apt B, Seaford, DE 19973-2449 Ph: (408) 394-9649 | Ethelind Cacho Cahigas, PT 529 N Porter St Apt B, Seaford, DE 19973-2449 Ph: (408) 394-9649 |
News Archive
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis.
caprotec bioanalytics GmbH, a privately held biopharmaceutical company offering the proprietary Capture Compound Mass Spectrometry platform technology for the analysis of small molecule – protein interactions, today announced a second closing of EUR 1 million to its Series B financing, increasing total equity for the round to EUR 5 million.
Amedisys Inc., one of the nation's largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Meanwhile McClatchy is reporting that, based on an analysis of Medicare's list of banned providers, Miami is at the top for Medicare fraud.
University of Michigan researchers have proven that a special surface, free of biological contaminants, allows adult-derived stem cells to thrive and transform into multiple cell types. Their success brings stem cell therapies another step closer.
XenoPort, Inc. announced today top-line results from its pivotal Phase 3 clinical trial of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis.
› Verified 4 days ago
Richard Sullivan, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 22830 & 22832 Sussex Highway, Suite 13 & 14, Seaford, DE 19973 Phone: 302-536-5562 Fax: 302-628-5313 | |
Ms. Hannah Rae Porter, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 808 Middleford Rd, Seaford, DE 19973 Phone: 302-629-4024 Fax: 302-629-6371 | |
Nicholas Elliot Galeone, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 15 Fallon Ave, Seaford, DE 19973 Phone: 302-536-1774 Fax: 302-536-7096 | |
Clement Raymond Tajon, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 Middleford Rd, Seaford, DE 19973 Phone: 302-629-6611 | |
Ekta Sharma, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 King Street, Lofland Park Center, Seaford, DE 19973 Phone: 302-628-3000 | |
Mr. Percival Corpuz Jr., Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 715 E King St, Seaford, DE 19973 Phone: 610-925-4148 Fax: 610-347-4948 | |
Genevieve Luzano, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1310 Middleford Rd Ste 101, Seaford, DE 19973 Phone: 919-258-2714 Fax: 410-648-4878 |